Published in Adv Exp Med Biol on January 01, 1988
Plasma amino acids concentration in amyotrophic lateral sclerosis patients. Amino Acids (2003) 0.89
Serum fibroblast growth factor 21 is predictive of combined cardiovascular morbidity and mortality in patients with type 2 diabetes at a relatively short-term follow-up. Diabetes Res Clin Pract (2013) 0.86
Lipid and lipoprotein ratios as risk factors of atherosclerosis in patients with chronic renal insufficiency (CRI). Int Urol Nephrol (1999) 0.83
Low-T3 syndrome and signal-averaged ECG in haemodialysed patients. Physiol Res (2005) 0.83
Concentration of Lp(a) and other apolipoproteins in predialysis, hemodialysis, chronic ambulatory peritoneal dialysis and post-transplant patients. Clin Chem Lab Med (2000) 0.83
[Bilateral peripheral facial nerve palsy in acute poisoning with ethylene glycol]. Pol Tyg Lek (1991) 0.82
Serum levels of IL-6 in mycosis fungoides, psoriasis, and lichen planus. Ann N Y Acad Sci (1995) 0.82
Cladribine treatment of multiple sclerosis. Lancet (1994) 0.81
Rate of Staphylococcus aureus nasal carriage in immunocompromised patients receiving haemodialysis treatment. Int J Antimicrob Agents (2001) 0.80
Dopamine-beta-hydroxylase activity and catecholamine levels in the plasma of patients with renal failure. Nephron (1979) 0.80
[Use of bioimpedance spectroscopy techniques for monitoring fluid balance in patients with end stage renal failure]. Przegl Lek (2000) 0.80
The central action of beta-adrenergic receptor blocking agents. I. The central action of intraventricularly administered isoprenaline in the rat. Pol J Pharmacol Pharm (1974) 0.80
Sialic acids of young and old red blood cells in healthy subjects. Med Sci Monit (2001) 0.80
[Sugar units, chemotypes and serotypes of Leptospira]. Z Naturforsch B (1968) 0.79
[The response to the hepatitis B virus vaccine in patients undergoing hemodialysis and peritoneal dialysis--personal experience]. Przegl Lek (1995) 0.78
Chronic myelogenous leukaemia associated with rapidly progressive glomerulonephritis. Nephrol Dial Transplant (1994) 0.78
Effect of parenteral cladribine on relapse rates in patients with relapsing forms of multiple sclerosis: results of a 2-year, double-blind, placebo-controlled, crossover study. Mult Scler (2009) 0.77
[Evaluation of the relationship between possible control of anemia in hemodialysis patients and the concentration of leptin]. Pol Arch Med Wewn (1999) 0.77
The relationship between serum level of N-terminal pro-B-type natriuretic peptide and nutritional status, and inflammation in chronic hemodialysis patients. Clin Nephrol (2010) 0.76
[Evaluation of the activity of the adrenergic and serotoninergic systems in chronic renal failure in humans and in rats with experimental uremia]. Pol Tyg Lek (1978) 0.76
[Acute non-inflammatory renal failure after transurethral electroresection of the prostate combined with irrigation of the bladder with distilled water]. Wiad Lek (1989) 0.76
Changing relationships between serum IL-1, IL-6, and TNF-alpha and dynamic tests of parathyroid gland function in haemodialysis patients with severe hyperparathyroidism in response to calcitriol therapy. Nephrol Dial Transplant (2000) 0.76
Magnesium concentration in plasma and erythrocytes in MS. Acta Neurol Scand (1995) 0.76
Serial cytokine changes in peritoneal effluent and plasma during peritonitis in patients on continuous ambulatory peritoneal dialysis (CAPD). Inflamm Res (1997) 0.76
[Relationships between hyperparathyroidism and Helicobacter pylori infection in long-term hemodialysis patients]. Pol Arch Med Wewn (2001) 0.76
Plasma amino acids percentages in amyotrophic lateral sclerosis patients. Neurol Sci (2003) 0.75
Successful pregnancy in a chronically hemodialyzed patient with end-stage renal failure. Indian J Nephrol (2009) 0.75
[Effect of vitamin E-modified membrane on expression of coreceptors CD4, CD8 on lymphocytes in chronic hemodialysis patients]. Przegl Lek (2001) 0.75
Effect of dialysate sodium on the dopamine, adrenaline and noradrenaline concentration in haemodialysis patients. Proc Eur Dial Transplant Assoc Eur Ren Assoc (1985) 0.75
Sympathetic activity response to changes in the intake of sodium in chronic renal failure. Int Urol Nephrol (1988) 0.75
[Radiologic picture of multi-organ calcification of soft tissues in patients with hemodialysis-treated renal failure]. Pol Przegl Radiol (1988) 0.75
Some hormones, minerals and vitamin D in continuous ambulatory peritoneal dialysis. Int Urol Nephrol (1987) 0.75
Use of double contrast estimation in diagnosis of upper gastrointestinal tract in hemodialysed patients. Ann Univ Mariae Curie Sklodowska Med (1990) 0.75
Leukopenia with different regenerated haemodialysis membranes. Int Urol Nephrol (1984) 0.75
[Albumin loss during treatment with intermittent and continuous dialyses using 2, 5 L of fluid per one exchange]. Wiad Lek (1985) 0.75
Evaluation of immunoglobulins, proinflammatory cytokines and lipid concentrations in patients with diabetic nephropathy treated with continual ambulatory peritoneal dialysis (CAPD). Ann Univ Mariae Curie Sklodowska Med (2000) 0.75
[Measurement of fluid compartments using electrical bioimpedance for assessment of target weight in hemodialysis patients]. Przegl Lek (2000) 0.75
[Effect of arterio-venous fistula blood flow dynamics on ECG abnormalities in chronic hemodialysis patients]. Przegl Lek (2000) 0.75
Chlamydia trachomatis infection in chronically hemodialyzed patients. Rocz Akad Med Bialymst (2005) 0.75
[Changes in the taste threshold in patients with chronic renal failure, non-dialysed and treated by peritoneal dialysis and hemodialysis]. Pol Arch Med Wewn (1986) 0.75
The effect of sulphinpyrazone and alpha-tocopherol on platelet activation and function in haemodialysed patients. Int Urol Nephrol (1990) 0.75
[Comparison of selected parameters of dialysis quality in hemodialysis patients not requiring and requiring treatment with erythropoietin]. Pol Arch Med Wewn (1995) 0.75
[Kinetics of continuous ambulatory peritoneal dialysis. II. Protein and immunoglobulin losses]. Pol Arch Med Wewn (1981) 0.75
[Treatment of a pregnant patient with advanced renal failure by repeated dialysis]. Pol Tyg Lek (1985) 0.75
[Activity of the kinin and renin systems in patients treated with hemodialysis using acetate and bicarbonate liquid]. Pol Tyg Lek (1985) 0.75
[Comparison of the ability to control anemia in patients on hemodialysis and peritoneal dialysis considering iron reserves and plasma erythropoietin]. Pol Arch Med Wewn (1996) 0.75
[Lupus nephropathy and pregnancy]. Wiad Lek (1987) 0.75
The effect of subcutaneous recombinant human erythropoietin (r-Hu EPO) in CAPD patients with renal anaemia. Ann Univ Mariae Curie Sklodowska Med (1994) 0.75
Effect of vitamin E modified cellulose membrane on human lymphocyte, monocyte, and granulocyte CD11b/CD18 adhesion molecule expression during hemodialysis. ASAIO J (2001) 0.75
Peritoneal dialysis adequacy during the r-Hu EPO treatment. Ann Univ Mariae Curie Sklodowska Med (1994) 0.75
[Late abdominal wall leaks of dialysis fluid--own experience in conservative treatment]. Wiad Lek (2001) 0.75
[Plasma levels of various catecholamines in schizophrenic patients during treatment with chlorpromazine]. Psychiatr Pol (1988) 0.75
[Evaluation of sialic acid levels in serum and degree of sialic acid in gamma-globulin fraction and C-reactive protein in hemodialysed patients]. Wiad Lek (1994) 0.75
[Nephrotic syndrome in syphilis]. Wiad Lek (1986) 0.75
Comparison of plasma erythropoietin concentrations and iron status in hemodialyzed patients not requiring and requiring rHuEpo therapy. Nephron (1996) 0.75
Serum sialic acid concentration and glycoprotein sialosylation in relation to temporary development of experimental alloxan induced diabetes in rabbits. Ann Univ Mariae Curie Sklodowska Med (1999) 0.75
[Evaluation of platelet function during treatment with recombinant human erythropoietin (r-HuEPO) in patients hemodialyzed and dialyzed peritoneally]. Wiad Lek (1993) 0.75
[Activation of blood platelets and the plasma coagulation system in patients with chronic uremia]. Pol Tyg Lek (1987) 0.75
Recurrent acute renal failure and polyps of the colon. Clin Nephrol (1993) 0.75
[Effectiveness of intermittent peritoneal dialysis conducted by the manual method using commercially available dialysis fluid]. Pol Arch Med Wewn (1984) 0.75
Changes of endogenous erythropoietin level and iron status during a 30-month hemodialysis treatment of a group of patients. Int Urol Nephrol (2001) 0.75
[Comparison of the effectiveness of peritoneal dialyses conducted by continuous and intermittent methods]. Pol Arch Med Wewn (1986) 0.75
Membrane ATPase, erythrocyte sodium and potassium in haemodialysis patients. Int Urol Nephrol (1991) 0.75
[Blood levels of immunoglobulins G,A,M, circulating immune complexes, complement and proteins in patients on intermittent peritoneal dialysis]. Pol Tyg Lek (1990) 0.75
[Mechanical complications connected with obtaining temporary access to blood vessels in a patient with chronic renal failure treated with hemodialysis]. Przegl Lek (1992) 0.75
Sympathetic activity, plasma renin activity (PRA) and kininogen levels in patients haemodialysed with acetate and bicarbonate. Int Urol Nephrol (1984) 0.75
[Complication due to intraperitoneal dialysis catheter insertion]. Pol Tyg Lek (1996) 0.75
[Selected aspects of rehabilitation programs for hemodialyzed patients in the United States ]. Przegl Lek (2000) 0.75
Searching for a genetic risk profile in end-stage renal disease. Med Sci Monit (2001) 0.75
[Effect of vitamin E on platelet function and anemia in patients on long-term hemodialysis]. Pol Tyg Lek (1988) 0.75
[Nephrotic syndrome in a patient with chronic myeloid leukemia]. Pol Tyg Lek (1988) 0.75
[Comparison of clinical parameters of chronically hemodialyzed patients not requiring treatment with erythropoietin and patients treated with erythropoietin]. Pol Arch Med Wewn (1994) 0.75
[Pulmonary embolism as a complication of nephrotic syndrome--case report and therapeutic management]. Wiad Lek (1997) 0.75
[Granulomatous interstitial nephritis associated with glomerular changes in the IgA nephropathy type]. Patol Pol (1985) 0.75
[Factors affecting the effectiveness of peritoneal dialysis]. Przegl Lek (1987) 0.75
[Infection with HCV in patients hospitalized for various causes. I. Prevalence of anti-HCV antibodies in selected groups of patients]. Przegl Epidemiol (1995) 0.75
Ferrum, copper, zinc and manganese in tissues of patients treated with long-standing hemodialysis programme. Ann Univ Mariae Curie Sklodowska Med (1994) 0.75
[Successful pregnancy outcome in a patient with acute renal failure superimposed on chronic renal failure treated with repeated hemodialysis]. Wiad Lek (1993) 0.75
Subcutaneous r-HuEPO therapy in CAPD patients: dose determination and clinical experience. Int Urol Nephrol (1998) 0.75
[Renin-angiotensin system genes in chronic glomerulonephritis]. Pol Arch Med Wewn (2001) 0.75
Diurnal rhythm of blood pressure, heart rate and adrenergic activity in patients with normotension treated with continuous ambulatory peritoneal dialysis and haemodialysis. Rocz Akad Med Bialymst (2005) 0.75
[Acute non-inflammatory renal failure after captopril treatment of a patient with renovascular hypertension]. Pol Tyg Lek (1987) 0.75
Soluble and membrane bound IL-2 receptors (alpha and beta chains) in chronic hemodialyzed patients. Folia Histochem Cytobiol (1997) 0.75
Plasma erythropoietin level and iron reserves in haemodialysis patients with and without acquired cystic kidney disease. Int Urol Nephrol (1997) 0.75
[2 cases of acute irreversible renal failure]. Wiad Lek (1984) 0.75
[Catecholamine levels in the brain of pt rabbits]. Neuropatol Pol (1986) 0.75
Phagocytic activity of polymorphonuclear leukocytes during haemodialysis in relation to some immunological findings. Int Urol Nephrol (1989) 0.75
High and low sodium acetate haemodialysis and ultrafiltration. II. Comparison of plasma renin activity (PRA), catecholamine levels (CA) and plasma aldosterone concentration (PAC). Int Urol Nephrol (1986) 0.75
[Analysis of circulating immune complexes with reference to DNA complexes in patients on hemodialysis and in those with chronic renal failure]. Pol Arch Med Wewn (1988) 0.75
Influence of intraperitoneal vancomycin on peritoneal dialysis efficiency. A clinical study. Int Urol Nephrol (1997) 0.75
Influence of some immune factors on the IL-6 and soluble IL-2 receptors in haemodialysed patients. Int Urol Nephrol (1997) 0.75
Pharmacokinetics of amoxycillin and ampicillin in patients with renal failure. Ann Univ Mariae Curie Sklodowska Med (1983) 0.75
[Effectiveness of peritoneal dialysis using dialysis fluid of modernized composition]. Wiad Lek (1990) 0.75
High and low sodium acetate haemodialysis and ultrafiltration. I. Comparison of haemodynamic effects. Int Urol Nephrol (1986) 0.75
[Does intraperitoneal vancomycin induce chemical peritonitis?]. Przegl Lek (1995) 0.75